Treatment of Acute Venous Thromboembolism.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 32505257.
- Also identified by DOI 10.1016/j.mcna.2020.03.004.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
"Acute venous thromboembolism is a common disease seen by nearly all hospitalists. The advent of low molecular weight heparin (LMWH) several decades ago ushered in the era of early hospital discharge and home treatment. More recently, the direct oral anticoagulants (DOACs) have further simplified outpatient treatment and some offer treatment without parenteral therapy. Use of DOACs for cancer-associated venous thromboembolism is emerging and is a welcome evolution of care to spare oncologic patients the burden of daily LMWH injections."
Medical subject headings
- Anticoagulants
- Venous Thromboembolism
- Venous Thrombosis